Atlantic Investment Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$522K Buy
3,775
+95
+3% +$15K 1.52% 24
2015
Q2
$565K Hold
3,680
1.35% 25
2015
Q1
$588K Hold
3,680
1.15% 26
2014
Q4
$586K Buy
+3,680
New +$573K 0.82% 26
2014
Q3
Sell
-4,015
Closed -$524K 29
2014
Q2
$475K Hold
4,015
0.41% 34
2014
Q1
$495K Hold
4,015
0.48% 32
2013
Q4
$458K Hold
4,015
0.4% 32
2013
Q3
$449K Hold
4,015
0.29% 32
2013
Q2
$396K Buy
+4,015
New +$417K 0.29% 34

Other funds holding AMGN

Atlantic Investment Company's AMGN Position: Q3 2015 in Review

Atlantic Investment Company increased its Amgen (AMGN) stake by 2.6% in Q3 2015, buying an estimated $15K and bringing the position to 3,775 shares worth $522K. The position accounts for 1.52% of the portfolio, ranked #24.

Atlantic Investment Company first reported a position in AMGN in Q2 2013 and has held it in 9 quarters since. The position peaked at $588K in Q1 2015. 1,380 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • Atlantic Investment Company held 3,775 shares of Amgen worth $522K as of Q3 2015.
  • Atlantic Investment Company bought 95 Amgen shares in Q3 2015, an estimated $15K.
  • Amgen made up 1.52% of Atlantic Investment Company's portfolio in Q3 2015, its #24 holding.
  • Atlantic Investment Company first reported a position in Amgen in Q2 2013 and has held it in 9 quarters since.
  • Atlantic Investment Company's Amgen position peaked at $588K in Q1 2015.
  • 1,380 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Atlantic Investment Company's 13F filing for Q3 2015, filed 13 Nov 2015.